Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression In the phase II ENACT (ClinicalTrials.gov identifier: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results